The FDA has provided a document attached to support product reformulation for products that contain Carbomer manufactured with Benzene.
The FDA has requested the USP to remove the impacted carbomers from THE Pharmacopoeia by 2025.
In response to the FDA REQUEST the USP issued a Notice of Intent to Revise, stating that it intends to omit the Carbomer 934, Carbomer 934P, Carbomer 940, Carbomer 941, and Carbomer 1342 monographs, with a targeted official date of August 1, 2025. See here for more details.
